Long-term defects of nasal epithelium barrier functions in patients with nasopharyngeal carcinoma post chemo-radiotherapy
The half-lives of compounds 1 , 2 , 5 , 9 , 11 , 14 , 16 , 22 and 23 in presence of NEP 24.11 and in presence of mouse plasma were determined by following the decay of the analogues by LCMS (Table 2)
By increasing metabolism and potentially improving exercise performance, NAD therapy may contribute to weight management
Getting prescribed Ozempic, Mounjaro, or another GLP-1 drug is just the tip of the iceberg
A pivotal shift occurred on December 1, 2025, when the World Health Organization (WHO) released its first-ever clinical guidelines recommending GLP-1 receptor agonists for the long-term treatment of obesity